| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Agape ATP Corporation$3.22
-0.41 (-11.29%)
Market Cap
2.78 M
EPS
-
P/E Ratio
-
Value Trade
20.53 M
SEC Financials
Q1 2026Dilution Risk
Revenue
273.66 K
Operating CF
-394.77 K
Total Assets
24.91 M
Total Liabilities
2.84 M
Equity
22.12 M
D/E Ratio
12,345
25.23 %
Week
15.83 %
1 Month
33.01 %
3 Month
-95.66 %
6 Month
-99.96 %
5 Year
-99.95 %
All Time
Cash Data
Cash Position
24.34 M
Monthly Burn
132.00 K
Runway
183.3 mo
Burn Trend
SEC Filing
May 15, 2026
Overview
Volume
146.09 K
52 Week Range
1.72 - 107
% held by Insiders
52.57 %
% held by Institutions
2.62 %
Enterprise Value
-21.43 M
Total Shares
50.05 M
Short %
1.32 %
Float Shares
23.72 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in ATPC
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
Agape ATP Corporation (ATPC) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
ATPC
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
ATPC
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
ATPC
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
ATPC Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
ATPC Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
ATPCAgape ATP Corporation Regains Compliance with Nasdaq Minimum Bid Price Requirement KUALA LUMPUR, MALAYSIA - 12 MARCH 2026 - Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Com
Agape ATP Corporation has announced that it has regained compliance with the Nasdaq minimum bid price requirement, following a notification of non-compliance on January 27, 2026. The company had been facing potential delisting after its common stock price fell below $1.00 for 30 consecutive days, but recent letters from Nasdaq indicated that it is now in compliance. Consequently, a scheduled hearing regarding the potential delisting has been canceled, allowing ATPC to remain listed on the Nasdaq Capital Market.
Read more →ATPCAGAPE ATP Corporation Forges Strategic Collaboration with UAE-Based Citadel Investment Partnership Strengthens Global Oil, Gas and Petrochemical Trading Network Across Key Interna
AGAPE ATP Corporation (ATPC) has announced a collaboration with UAE-based Citadel Investment LLC to explore opportunities in oil, gas, and petrochemical trading globally. This partnership aims to leverage both companies' networks and expertise to identify and structure transactions in the energy sector. The agreement will focus on building long-term relationships while complying with regulatory standards. Alongside expanding its portfolio, ATPC reinforces its strategic position in the global energy market.
Read more →ATPCAgape ATP Corporation Announces 1-For-50 Reverse Stock Split KUALA LUMPUR, MALAYSIA - 06 FEBRUARY 2026 - Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced th
Agape ATP Corporation has announced a 1-for-50 reverse stock split of its common stock, effective from February 9, 2026. The decision was approved by shareholders at the Annual Meeting on January 30, 2026. Following the split, the company's stock will trade on a reverse-adjusted basis on the Nasdaq market starting February 10, 2026. The company also outlined that fractional shares from the split will be rounded up to whole shares, and adjustments will be made to outstanding equity awards accordingly.
Read more →ATPCAgape ATP Corporation Receives Nasdaq Notice on Minimum Bid Price Requirement
Agape ATP Corporation received a notice from Nasdaq for failing to meet minimum bid price requirements. The notification is based on the company's stock performance from late 2025 to January 2026. The company has been given a compliance period of 180 days to meet the requirement or risk delisting. ATPC is currently assessing options to regain compliance, which may include a reverse stock split.
Read more →ATPCAgape ATP Corporation Issues Statement on Recent Market Activity and Reaffirms Strategic Outlook
Agape ATP Corporation (ATPC) has issued a statement regarding the recent volatility in its stock price, affirming that business operations remain stable and that there are no undisclosed adverse conditions impacting its performance. The company's management is focusing on diversifying its operations in health and wellness and sustainable energy for long-term value. ATPC is committed to keeping investors informed through timely disclosures and regulatory filings, reiterating its dedication to its strategic outlook.
Read more →ATPCAgape ATP Corporation Signs Strategic Partnerships Agreement to Advance Global Energy and Infrastructure Initiatives Collaborations with Global Strategic Solutions and BM Trading
Agape ATP Corporation (ATPC) has signed a strategic partnership agreement with Global Strategic Solutions LLC and BM Trading Services. This alliance aims to advance large-scale energy and infrastructure initiatives across Southeast Asia, Africa, and Eastern Europe. ATPC will provide engineering and procurement services, while GSS will handle project identification and investor engagement. This partnership is set for an initial exclusivity period of three years, which emphasizes the companies' commitment to mutually beneficial projects in these high-potential markets.
Read more →ATPCAgape ATP Corporation Secured Landmark Jet Fuel Supply Agreement with Swiss One Oil & Gas AG Strategic partnership positions ATPC for long-term growth in the global energy market KUALA LUMPUR, 3 APRIL 2025 - NASDAQ-liste
Agape ATP Corporation (ATPC) has secured a significant jet fuel supply agreement with Swiss One Oil & Gas AG, valued at approximately USD 24 billion. This partnership, building upon an initial purchase order, involves the supply of refined fuels including Jet Fuel A1 and EN590 10PPM diesel over a structured long-term agreement. The initial trial order is set for completion with substantial weekly deliveries anticipated to fulfill growing market demand. The agreement is expected to greatly enhance ATPC's revenue and align with its vision for sustainable business growth.
Read more →ATPCAgape ATP Corporation Successfully Completes $23 Million Private Placement, Strengthening Growth Across Key Sectors Strong investor confidence fuels ATPC's expansion in healthcare, oil & gas trading, and renewable energy
Agape ATP Corporation (ATPC) has successfully completed a $23 million private placement, enhancing its financial position and facilitating growth in key sectors such as healthcare, oil & gas trading, and renewable energy. The issuance involved 46 million shares at a price of $0.50 each, attracting significant participation from institutional investors. The raised capital will be used to further develop ATPC's projects and initiatives aimed at improving health and wellness solutions while also scaling sustainable energy endeavors.
Read more →ATPCAgape ATP Corporation Announces Key USD23.0 Million Private Placement to Institutional Investors Strategic funding to accelerate ATPC's expansion in healthcare, oil & gas, and ren
Agape ATP Corporation (ATPC) has announced a $23 million private placement with institutional investors, aimed at accelerating its expansion in healthcare, oil & gas, and renewable energy sectors. The transaction involves the issuance of 46 million shares at a price of $0.50 each and is scheduled to close within 30 business days. This funding reflects confidence in ATPC's long-term strategy, and marks a pivotal moment as the company forges partnerships, particularly in the oil and gas market. Additionally, the funds are expected to enhance operational capabilities and shareholder value.
Read more →ATPCATPC Expands Global Market Footprint to Spearhead Medical Innovation with MoUs in Indonesia Agreements to drive clinical research, enhance product safety, and combat respiratory diseases KUALA LUMPUR, 29 NOVEMBER 2024 -
Agape ATP Corporation (ATPC) has signed three Memorandums of Understanding (MOUs) with key healthcare institutions in Indonesia to enhance clinical research and address respiratory diseases such as tuberculosis and COPD. This strategic move underscores ATPC's commitment to medical innovation and improving health outcomes in Indonesia and Southeast Asia. The partnerships will focus on training healthcare professionals and ensuring compliance with local health regulations, while also aiming to align with the United Nations Sustainable Development Goals.
Read more →ATPCAgape ATP Corporation - Synergising Innovation Across Business Pillars to Make the World a Better Place ATPC Unveils Its Multifaceted Business Pillars to Drive Global Wellness and Sustainability KUALA LUMPUR, MALAYSIA, 1
Agape ATP Corporation (ATPC) has unveiled its multifaceted business pillars aimed at promoting global wellness and sustainability. The company emphasizes collaboration across sectors, focusing on areas such as nutraceuticals, anti-aging solutions, clean energy, and innovative healthcare devices. With ambitions to enhance quality of life, ATPC is positioning itself as a leader in segments including senior living and energy efficiency. Despite the promising outlook, the company acknowledges the uncertainties tied to market dynamics and regulatory environments.
Read more →ATPCAgape ATP Corporation Regains Compliance with Nasdaq's Minimum Bid Price Rule KUALA LUMPUR, 19 SEPTEMBER 2024 - AGAPE ATP Corporation ("ATPC" or the Company) , is pleased to annou
Agape ATP Corporation (ATPC) has successfully regained compliance with the Nasdaq Stock Market's minimum bid price rule, confirming that its ordinary shares were priced at $1.00 or higher for 10 consecutive trading days. This compliance notification was received on September 17, 2024, and closes the matter with Nasdaq. The company focuses on providing health, wellness products, and energy-saving solutions, positioning itself favorably in the market.
Read more →ATPCAGAPE ATP Corporation Addresses Recent Corporate Exercise and Strategic Developments Reverse Stock Split and New Initiatives to Drive Future Growth KUALA LUMPUR, MALAYSIA, AUGUST
AGAPE ATP Corporation (NASDAQ: ATPC) has announced a 1-for-20 reverse stock split aimed at boosting its share price and meeting NASDAQ listing standards, with the number of authorized shares reduced from 1 billion to 50 million. The company is also launching new products and initiatives in green energy and wellness, following a partnership that led to the establishment of ATPC Green Energy Sdn. Bhd. This strategic move aligns with ATPC's goals of promoting sustainability while enhancing shareholder value. Management reassures investors that these steps are part of a broader strategy aimed at ensuring long-term stability and growth.
Read more →ATPCAgape ATP Corporation Announces US$1 Million Share Repurchase Plan KUALA LUMPUR, 22 November 2023 - AGAPE ATP Corporation (NASDAQ: ATPC) ("ATPC" or the "Company") announced that on
Agape ATP Corporation has announced a share repurchase plan allowing the company to buy back up to US$1 million of its shares over the next six months. The board has appointed Network 1 Financial Securities to facilitate this process. Repurchases will depend on various factors including market conditions and regulatory compliance. The plan reflects the company's strategy to enhance shareholder value, although it is not obligated to repurchase a specific number of shares.
Read more →ATPCAGAPE ATP CORPORATION Statement of Policy Concerning Trading in Company Securities Adopted
AGAPE ATP CORPORATION has adopted a new statement of policy regarding trading in company securities. This policy mandates compliance with all applicable laws and regulations and emphasizes the importance of avoiding insider trading. It sets clear guidelines for the behavior of employees, executive officers, and directors when handling material information. Strict pre-approval requirements and limitations on trading are instituted to ensure the integrity of the company's operations and protect investor interests.
Read more →ATPCAGAPE SUPERIOR LIVING SDN. BHD. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS March 31
SUPERIOR LIVING SDN. BHD. CONDENSED CONSOLIDATED BALANCE SHEETS March 31, December 31, 2020 2019 ASSETS Current assets Cash $ 1,206,493 $ 1,030,829 Other receivables 33,210 34,672 Other receivables - related parties 219,121 233,942 Inve
Read more →ATPCAGAPE SUPERIOR LIVING SDN. BHD. CONSOLIDATED FINANCIAL STATEMENTS YEARS ENDED DECEMBER 31, 2019 AND 2018 AND REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AGAPE SUPERIOR LIVING SDN. BHD. INDEX TO CONSOLIDATED F
SUPERIOR LIVING SDN. BHD. FINANCIAL STATEMENTS ENDED DECEMBER 31, 2019 AND 2018 OF INDEPENDENT REGISTERED PUBLIC SUPERIOR LIVING SDN. BHD. TO CONSOLIDATED FINANCIAL STATEMENTS Consolidated Financial Statements Report of Independent Registered Public Accounting Firm F-3 Con
Read more →Competitive Position
How ATPC ranks across every disease it competes inCompetitive Position is a premium feature
See how ATPC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial